US Patent 7049328 Use for deferiprone
Patent 7049328 was granted and assigned to Apotex on May, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 26 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Nov, 2023
Golden AI
Edits made to:
Infobox (+10 properties)
Article (+356 characters)
Article
Patent abstract
A method of treating iron induced cardiac disease in a patient with iron overload, such as in thalassemia or the like comprising administering to the patient a therapeutically effective amount of deferiprone or a physiologically acceptable salt thereof sufficient to treat iron induced cardiac disease normally associated with iron overload.
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Antonio Piga0
Michael Spino0
Date of Patent
May 23, 2006
0Patent Application Number
103118140
Date Filed
June 28, 2001
0Patent Primary Examiner
Golden AI
Edits made to:
US Patent 7049328 Use for deferiprone
Find more entities like US Patent 7049328 Use for deferiprone
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.